phenol has been researched along with Liver Neoplasms in 13 studies
Liver Neoplasms: Tumors or cancer of the LIVER.
| Excerpt | Relevance | Reference |
|---|---|---|
| "According to WHO, Hepatocellular cancer (HCC) was the second leading cause of death in 2019 and is gradually increasing." | 5.91 | Identification of phenol 2,2-methylene bis, 6 [1,1-D] as breath biomarker of hepatocellular carcinoma (HCC) patients and its electrochemical sensing: E-nose biosensor for HCC. ( Abbas, SR; Nazir, NU, 2023) |
| "Erianin is a natural product extracted from Dendrobium, which possesses multiple pharmacological activities, including antioxidative and antitumor activity." | 5.56 | Erianin suppresses hepatocellular carcinoma cells through down-regulation of PI3K/AKT, p38 and ERK MAPK signaling pathways. ( Chen, Q; Hu, Y; Song, Z; Yang, L; Zhou, G, 2020) |
| "Hydroquinone (HQ) produced renal adenomas in male F344 rats, and these tumors appeared to arise from areas of spontaneous progressive nephropathy; the nephropathy itself has been found to be enhanced by HQ." | 4.79 | Analysis of studies related to tumorigenicity induced by hydroquinone. ( English, JC; Verna, L; Whysner, J; Williams, GM, 1995) |
| " This fraction contains a number of phenolic compounds, and this phenolic-rich EtOAC fraction was particularly effective against gastric and breast cancer cells." | 3.75 | Selective cytotoxic effects on human cancer cell lines of phenolic-rich ethyl-acetate fraction from Rhus verniciflua Stokes. ( Choi, YK; Go, HY; Hong, SI; Jang, BH; Jung, CH; Kim, JH; Ko, SG; Park, JH; Shin, YC, 2009) |
| "According to WHO, Hepatocellular cancer (HCC) was the second leading cause of death in 2019 and is gradually increasing." | 1.91 | Identification of phenol 2,2-methylene bis, 6 [1,1-D] as breath biomarker of hepatocellular carcinoma (HCC) patients and its electrochemical sensing: E-nose biosensor for HCC. ( Abbas, SR; Nazir, NU, 2023) |
| "Erianin is a natural product extracted from Dendrobium, which possesses multiple pharmacological activities, including antioxidative and antitumor activity." | 1.56 | Erianin suppresses hepatocellular carcinoma cells through down-regulation of PI3K/AKT, p38 and ERK MAPK signaling pathways. ( Chen, Q; Hu, Y; Song, Z; Yang, L; Zhou, G, 2020) |
| "The anti-liver cancer properties of erianin were found to be related mostly to its modulation of oxidative stress-mediated mitochondrial apoptosis and immune response." | 1.51 | The anti-carcinogenesis properties of erianin in the modulation of oxidative stress-mediated apoptosis and immune response in liver cancer. ( Li, X; Li, Z; Wang, D; Wang, Y; Yang, A; Zhang, X, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (7.69) | 18.7374 |
| 1990's | 1 (7.69) | 18.2507 |
| 2000's | 2 (15.38) | 29.6817 |
| 2010's | 3 (23.08) | 24.3611 |
| 2020's | 6 (46.15) | 2.80 |
| Authors | Studies |
|---|---|
| Sheng, Y | 1 |
| Chen, Y | 1 |
| Zeng, Z | 1 |
| Wu, W | 1 |
| Wang, J | 2 |
| Ma, Y | 1 |
| Lin, Y | 1 |
| Zhang, J | 1 |
| Huang, Y | 1 |
| Li, W | 2 |
| Zhu, Q | 1 |
| Wei, X | 1 |
| Li, S | 1 |
| Wisanwattana, W | 1 |
| Li, F | 1 |
| Liu, W | 1 |
| Suksamrarn, A | 1 |
| Zhang, G | 1 |
| Jiao, W | 1 |
| Wang, F | 1 |
| Chen, J | 2 |
| Liu, J | 2 |
| Xu, B | 1 |
| Cao, Y | 2 |
| Liang, X | 1 |
| Wu, F | 1 |
| Shen, X | 1 |
| Ma, X | 1 |
| Nazir, NU | 1 |
| Abbas, SR | 1 |
| Zhang, X | 1 |
| Wang, Y | 2 |
| Li, X | 1 |
| Yang, A | 1 |
| Li, Z | 1 |
| Wang, D | 1 |
| Yang, L | 1 |
| Hu, Y | 1 |
| Zhou, G | 1 |
| Chen, Q | 1 |
| Song, Z | 1 |
| Dong, H | 1 |
| Wang, M | 1 |
| Chang, C | 1 |
| Sun, M | 1 |
| Yang, F | 1 |
| Li, L | 1 |
| Feng, M | 1 |
| Zhang, L | 1 |
| Li, Q | 1 |
| Zhu, Y | 1 |
| Qiao, Y | 1 |
| Xie, T | 1 |
| Rolfs, F | 1 |
| Piersma, SR | 1 |
| Dias, MP | 1 |
| Jonkers, J | 1 |
| Jimenez, CR | 1 |
| Wang, L | 1 |
| Xu, J | 1 |
| Xu, G | 1 |
| Do Thi, N | 1 |
| Hwang, ES | 1 |
| Kim, JH | 1 |
| Jung, CH | 1 |
| Jang, BH | 1 |
| Go, HY | 1 |
| Park, JH | 1 |
| Choi, YK | 1 |
| Hong, SI | 1 |
| Shin, YC | 1 |
| Ko, SG | 1 |
| YAMANA, K | 1 |
| Gong, YQ | 1 |
| Fan, Y | 1 |
| Wu, DZ | 1 |
| Yang, H | 1 |
| Hu, ZB | 1 |
| Wang, ZT | 1 |
| Whysner, J | 1 |
| Verna, L | 1 |
| English, JC | 1 |
| Williams, GM | 1 |
1 review available for phenol and Liver Neoplasms
| Article | Year |
|---|---|
Analysis of studies related to tumorigenicity induced by hydroquinone.
Topics: Adenoma; Animals; Carcinogenicity Tests; Female; Humans; Hydroquinones; Kidney Neoplasms; Leukemia; | 1995 |
12 other studies available for phenol and Liver Neoplasms
| Article | Year |
|---|---|
Identification of Pyruvate Carboxylase as the Cellular Target of Natural Bibenzyls with Potent Anticancer Activity against Hepatocellular Carcinoma via Metabolic Reprogramming.
Topics: Antineoplastic Agents; Bibenzyls; Carcinoma, Hepatocellular; Cell Proliferation; Click Chemistry; Ge | 2022 |
Ethoxy-erianin phosphate and afatinib synergistically inhibit liver tumor growth and angiogenesis via regulating VEGF and EGFR signaling pathways.
Topics: Afatinib; Animals; Bibenzyls; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; ErbB | 2022 |
Identification of phenol 2,2-methylene bis, 6 [1,1-D] as breath biomarker of hepatocellular carcinoma (HCC) patients and its electrochemical sensing: E-nose biosensor for HCC.
Topics: Biomarkers; Biosensing Techniques; Breath Tests; Carcinoma, Hepatocellular; Electronic Nose; Gold; H | 2023 |
The anti-carcinogenesis properties of erianin in the modulation of oxidative stress-mediated apoptosis and immune response in liver cancer.
Topics: Animals; Anticarcinogenic Agents; Apoptosis; Bibenzyls; Humans; Liver Neoplasms; Mice; Mice, Inbred | 2019 |
Erianin suppresses hepatocellular carcinoma cells through down-regulation of PI3K/AKT, p38 and ERK MAPK signaling pathways.
Topics: Apoptosis; Bibenzyls; Carcinoma, Hepatocellular; Cell Proliferation; Down-Regulation; Drug Screening | 2020 |
Erianin inhibits the oncogenic properties of hepatocellular carcinoma via inducing DNA damage and aberrant mitosis.
Topics: Animals; Bibenzyls; Carcinogenesis; Carcinoma, Hepatocellular; Cell Proliferation; DNA Damage; Hep G | 2020 |
Feasibility of Phosphoproteomics on Leftover Samples After RNA Extraction With Guanidinium Thiocyanate.
Topics: Animals; Carcinoma, Hepatocellular; Cell Line; Chloroform; DNA Damage; Feasibility Studies; Guanidin | 2021 |
Molecular evidence for better efficacy of hypocrellin A and oleanolic acid combination in suppression of HCC growth.
Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Movement; Cell Proliferation; Cell Survival; | 2019 |
Effects of laver extracts on adhesion, invasion, and migration in SK-Hep1 human hepatoma cancer cells.
Topics: Antineoplastic Agents; beta Carotene; Carcinoma, Hepatocellular; Cell Adhesion; Cell Line, Tumor; Ce | 2014 |
Selective cytotoxic effects on human cancer cell lines of phenolic-rich ethyl-acetate fraction from Rhus verniciflua Stokes.
Topics: Acetates; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Carcinoma, Hepatocellular; Cell Divisi | 2009 |
Fractionation of ribonucleic acids with phenol. II. The relationship between RNA fractions in rat ascites hepatoma.
Topics: Ascites; Carcinoma, Hepatocellular; Chemical Fractionation; Liver Neoplasms; Neoplasms; Phenol; Phen | 1960 |
In vivo and in vitro evaluation of erianin, a novel anti-angiogenic agent.
Topics: 3T3 Cells; Angiogenesis Inhibitors; Animals; Bibenzyls; Carcinoma, Hepatocellular; Drug Evaluation, | 2004 |